David R Langley
2PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|May 31, 2024
Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer Models.Sheryl M Gough, John J Flanagan, Jessica Teh
|Jan 19, 2022
PROTAC targeted protein degraders: the past is prologue.Miklós Békés, David R Langley, Craig M Crews
Pageof 1
Frequent Collaborators
2 joint publications
Miklós Békés
1 joint publications
Craig M Crews
1 joint publications
Sheryl M Gough
1 joint publications
John J Flanagan
1 joint publications
Jessica Teh
1 joint publications
Monica Andreoli
1 joint publications
Emma Rousseau
1 joint publications
Melissa Pannone
1 joint publications
Mark Bookbinder
1 joint publications
Ryan Willard
